NCT03442621 - Relacorilant Food Effect Study in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

February 28, 2018

Study Completion Date

March 9, 2018

Conditions

HealthyFood-drug Interaction

Interventions

DRUG

Relacorilant Fasted

Relacorilant, presented as 7 x 50-mg white, hard gelatin capsules for oral administration, given following a 10.5 h fast

DRUG

Relacorilant with a high fat breakfast

Relacorilant presented as 7 x 50-mg white, hard gelatin capsules for oral administration, given following a 10 h fast and 0.5 h after the start of a high fat breakfast

DRUG

Relacorilant with a moderate breakfast

Relacorilant, presented as 7 x 50-mg white, hard gelatin capsules for oral administration, given following a 10 h fast and 0.5 h after the start of a moderate breakfast

Trial Locations (1)

85283

Celerion, Tempe